Who Paid My Doc
P2b SLE Dose-Finding
Research payments
$931,728
Through program year 2024, $931,728 in research payments was reported against P2b SLE Dose-Finding, across 110 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $48,262 | 6 |
| 2023 | Research | $331,386 | 37 |
| 2022 | Research | $552,080 | 67 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Victoria Werth Philadelphia, PA Named on 6 payments
- Steve Lee Fontana, CA Named on 4 payments
- Samy Metyas Covina, CA Named on 4 payments
- Kenneth Kalunian San Diego, CA Named on 4 payments
- Alireza Nami Charlotte, NC Named on 4 payments
- Kyriakos Kirou New York, NY Named on 3 payments
- Cynthia Aranow Manhasset, NY Named on 3 payments
- Violeta Rus Baltimore, MD Named on 3 payments
- Fotios Koumpouras North Haven, CT Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.